Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice

BACKGROUND AND OBJECTIVE: Lipoid congenital adrenal hyperplasia (LCAH) is the most severe form of adrenal hyperplasia and mutations in the StAR gene are the most common cause of the disease. Adrenal insufficiency and cholestasis are reported in few patients. The aim of this study was to report the r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A Homaei, A Heidari, F Saffari
Formato: article
Lenguaje:EN
FA
Publicado: Babol University of Medical Sciences 2021
Materias:
R
Acceso en línea:https://doaj.org/article/ce8e92a798b04d9b89a6450623cf94b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ce8e92a798b04d9b89a6450623cf94b6
record_format dspace
spelling oai:doaj.org-article:ce8e92a798b04d9b89a6450623cf94b62021-11-29T07:40:49ZLipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice1561-41072251-7170https://doaj.org/article/ce8e92a798b04d9b89a6450623cf94b62021-03-01T00:00:00Zhttp://jbums.org/article-1-9516-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: Lipoid congenital adrenal hyperplasia (LCAH) is the most severe form of adrenal hyperplasia and mutations in the StAR gene are the most common cause of the disease. Adrenal insufficiency and cholestasis are reported in few patients. The aim of this study was to report the results of treatment of two sisters with lipoid CAH and cholestatic jaundice. CASE REPORTS: Here, we present two sisters at the age of 30 and 60 days with conjugated hyperbilirubinemia and elevated liver enzymes and adrenal insufficiency. They had a 46,XY karyotype with external female genitalia without uterus and ovaries. LCAH was detected through electrolyte abnormalities, increased ACTH, decreased levels of cortisol and sex hormones and was confirmed by determination of exome sequencing and Sanger sequencing. In these patients, a homozygous mutation (c.653C>T) in exon 6 of STAR gene was identified. The patients were treated with 10 mg of hydrocortisone IV every 8 hours for 3 days; oral hydrocortisone was then administered at a dose of 2.5 mg every 8 hours and 0.2 mg fludrocortisone daily. One month after the therapy, levels of bilirubin and liver enzymes of these patients became normal. The first patient died 7 months after her mother stopped giving the drugs to the child. The other patient is now 9 years old. She is in good clinical condition as her treatment goes on. CONCLUSION: Considering the reported cases, adrenal lipoid hyperplasia should be considered as a rare cause of cholestasis with adrenal insufficiency in patients.A HomaeiA HeidariF SaffariBabol University of Medical Sciencesarticlelipoid cahadrenal insufficiencyneonatal cholestasiskaryotype.MedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 23, Iss 1, Pp 119-125 (2021)
institution DOAJ
collection DOAJ
language EN
FA
topic lipoid cah
adrenal insufficiency
neonatal cholestasis
karyotype.
Medicine
R
Medicine (General)
R5-920
spellingShingle lipoid cah
adrenal insufficiency
neonatal cholestasis
karyotype.
Medicine
R
Medicine (General)
R5-920
A Homaei
A Heidari
F Saffari
Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
description BACKGROUND AND OBJECTIVE: Lipoid congenital adrenal hyperplasia (LCAH) is the most severe form of adrenal hyperplasia and mutations in the StAR gene are the most common cause of the disease. Adrenal insufficiency and cholestasis are reported in few patients. The aim of this study was to report the results of treatment of two sisters with lipoid CAH and cholestatic jaundice. CASE REPORTS: Here, we present two sisters at the age of 30 and 60 days with conjugated hyperbilirubinemia and elevated liver enzymes and adrenal insufficiency. They had a 46,XY karyotype with external female genitalia without uterus and ovaries. LCAH was detected through electrolyte abnormalities, increased ACTH, decreased levels of cortisol and sex hormones and was confirmed by determination of exome sequencing and Sanger sequencing. In these patients, a homozygous mutation (c.653C>T) in exon 6 of STAR gene was identified. The patients were treated with 10 mg of hydrocortisone IV every 8 hours for 3 days; oral hydrocortisone was then administered at a dose of 2.5 mg every 8 hours and 0.2 mg fludrocortisone daily. One month after the therapy, levels of bilirubin and liver enzymes of these patients became normal. The first patient died 7 months after her mother stopped giving the drugs to the child. The other patient is now 9 years old. She is in good clinical condition as her treatment goes on. CONCLUSION: Considering the reported cases, adrenal lipoid hyperplasia should be considered as a rare cause of cholestasis with adrenal insufficiency in patients.
format article
author A Homaei
A Heidari
F Saffari
author_facet A Homaei
A Heidari
F Saffari
author_sort A Homaei
title Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
title_short Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
title_full Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
title_fullStr Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
title_full_unstemmed Lipoid Congenital Adrenal Hyperplasia with Cholestatic Jaundice
title_sort lipoid congenital adrenal hyperplasia with cholestatic jaundice
publisher Babol University of Medical Sciences
publishDate 2021
url https://doaj.org/article/ce8e92a798b04d9b89a6450623cf94b6
work_keys_str_mv AT ahomaei lipoidcongenitaladrenalhyperplasiawithcholestaticjaundice
AT aheidari lipoidcongenitaladrenalhyperplasiawithcholestaticjaundice
AT fsaffari lipoidcongenitaladrenalhyperplasiawithcholestaticjaundice
_version_ 1718407551980142592